The Jordan B. Peterson Podcast - 299. Psychedelic Science | Dr. Dennis McKenna
Episode Date: October 25, 2022Dr. Peterson's extensive catalog is available now on DailyWire+: https://utm.io/ueSXh Dr. Jordan B. Peterson and Dr. Dennis McKenna discuss the science behind psychedelics, the entities found through... the looking glass, the current pharmaceutical approach to long life, and why it needs to change. Dr. Dennis McKenna is an American ethnopharmacologist, lecturer and author. He is a founding board member and the director of ethnopharmacology at the Heffter Research Institute, a non-profit exploring the therapeutic uses of psychedelic medicines. McKenna received his masters in botany at the University of Hawaii in 1979, followed by his doctorate in the same field at the University of British Columbia in 1984. Dennis is the brother of Terrence McKenna, a cultural figure and proponent for the exploration of psychedelics. Together they co-authored The Invisible Landscape. Much later Dennis would write a memoir, Brotherhood of the Screaming Abyss,  detailing he and his brothers exploits in the field. Today, Dennis tours and lectures, while also running the McKenna Academy of Natural Philosophy, which seeks to uncover the mysteries of consciousness held within the realm of botany and pharmacology. —Links— McKenna Academy: https://mckenna.academy The Experiment at La Chorrera https://mckenna.academy/events?id=32 ESPD55 Livestream Symposium ESPD55.com Those interested in donations may contact connect@mckenna.academy - Sponsors - Birch Gold - Text "JORDAN" to 989898 for your no-cost, no-obligation, FREE information kit Elysium Health - Save 25% off Basis monthly subscriptions with code JBP25: https://trybasis.com/Jordan Shopify - Get a FREE 14-day trial with full access to Shopify's entire suite of features: https://shopify.com/jbp - Chapters - (0:00) Coming up(0:40) intro(2:33) Dr. Dennis McKenna now(6:47) What is ethnopharmacology?(12:45) Ayahuasca(26:02) Hierarchy of concepts(30:00) The Reality Hallucination(43:50) Breaking down hyper reality(49:30) Commonalities of entities(55:50) The intrinsic form of personality(1:00:15) Ritual, bad shamans(1:02:58) Carl Rogers, voluntary exposure(1:09:15) Roland Griffiths, the flaw in how medicine is practiced(1:12:05) Impending mortality(1:24:45) Dr. McKenna’s future plans(1:26:19) Looking back at a life long career  // SUPPORT THIS CHANNEL //Newsletter: https://mailchi.mp/jordanbpeterson.com/youtubesignupDonations: https://jordanbpeterson.com/donate // COURSES //Discovering Personality: https://jordanbpeterson.com/personalitySelf Authoring Suite: https://selfauthoring.comUnderstand Myself (personality test): https://understandmyself.com // BOOKS //Beyond Order: 12 More Rules for Life: https://jordanbpeterson.com/Beyond-Order12 Rules for Life: An Antidote to Chaos: https://jordanbpeterson.com/12-rules-for-lifeMaps of Meaning: The Architecture of Belief: https://jordanbpeterson.com/maps-of-meaning // LINKS //Website: https://jordanbpeterson.comEvents: https://jordanbpeterson.com/eventsBlog: https://jordanbpeterson.com/blogPodcast: https://jordanbpeterson.com/podcast // SOCIAL //Twitter: https://twitter.com/jordanbpetersonInstagram: https://instagram.com/jordan.b.petersonFacebook: https://facebook.com/drjordanpetersonTelegram: https://t.me/DrJordanPetersonAll socials: https://linktr.ee/drjordanbpeterson #JordanPeterson #JordanBPeterson #DrJordanPeterson #DrJordanBPeterson #DailyWirePlus #podcast #DennisMcKennaÂ
Transcript
Discussion (0)
Hello everyone, thank you for tuning in and watching and listening. I'm very pleased
today to have with me, Dr. Dennis McKenna. He's an American ethno-pharmacologist, lecture and author.
He is a founding board member and director
of ethno-pharmacology at Hefter Research Institute,
a non-profit organization dedicated to the use
and the exploration of psychedelic medicines.
Dr. McKenna received his PhD
from the University of British Columbia
and worked as a post-doc
at the National Institute of Mental Health and at Stanford.
He is the brother of Terence McKenna,
who believed that the human relationship
with psychedelic plants played a major role
in our cognitive and social evolution,
who's a very well-known figure
to denizens of the modern psychedelic movement.
Dr. McKenna and I first met some years ago,
2016 in Toronto at a conference hosted by mine matters
at the University of Toronto,
where we shared our views on the potential significance
of altered states of consciousness.
It's really good to see again, Dennis.
Thanks very much for agreeing to do this podcast.
Thank you so much, Dr. Peterson. It's a pleasure to be invited. I'm very happy to be here.
It's nice to see you again after eight years. So neither you nor I were famous at that time. Now you're quite famous and I'm a little more well-dove.
So time passes.
Yeah.
Well, it's very good to see you.
So tell me what you're up to recently.
As you said, we haven't spoken for a number of years.
So what are you busy doing now?
Well, basically, so I immigrated to Canada in 2019 and I left academia. I left the University
of Minnesota immigrated up here with my wife. And I started a nonprofit called the Mechanical
Academy for Natural Philosophy. And originally, it was incorporated here in Canada,
but then we dissolved that and incorporated in the states
because it made more sense.
And the mechanical academy, if for natural philosophy,
is basically devoted to education,
as you can tell by the name, primarily,
about psychedelics and plant medicines.
Originally, our vision for it was to do retreats and conferences
and that sort of thing.
But in 2020, COVID came along and kind of put a spike in that.
So the last actual physical conference we did before COVID
was in 2019 in South America.
We did a mystery school retreat
with my friend, Alexandra Tanou,
who is an ethno musicologist.
There's that ethno term again.
And then we did a lot of online events.
We offered a six week long ethno botany course
in collaboration with the organization
for Tropical Studies.
In this year, we did our first physical conference
since COVID in the UK.
That was called ESPD 55, which is ESPD stands for the
Ethno Pharmacologic Search for Psychoactive Drugs. And 55 is, which was sponsored by the National Institute
of Mental Health in 1967. And I actually did an ESPD 50 in 2017, but that was before the
McKenna Academy was formed. So we did these two, and people can look at ESPD55.com. It's open access and see what we
talked about. It was very well received. It was at this beautiful venue in Yorkshire
and in Dorset, I guess it was, and it was very well received, and we had 37 speakers covering
whole range of topics related to this general topic of the etho-pharmacologic search for
psychoactive drugs.
So that's what I've been doing, Jordan, basically working through the academy and doing that
sort of thing.
Maybe we could let everybody watching and listening know a little bit more about what
ethno-botany is exactly.
Sure.
So could you elaborate on that?
Sure.
Well, ethno-pharmacology is, so I like to term it.
So ethno-pharmacology has a kind of formal definition, if you want to get down in the weeds with it.
But I kind of like the formal definition for a couple of reasons.
Ethno-pharmacology is the interdisciplinary scientific investigation of biologically active substances
of biologically active substances used or observed by humans in traditional societies. So it's a kind of a, you might say tortured definition, but there's a reason for that.
For one thing, it's not, it's study is not confined to plants. It includes fungi and anything that may have
biologically-active substances.
It's not necessarily about medicines.
For example, arrow poisons are certainly within the purview
of the study of ethofarmacology
or any kind of biologically active substances, fish poisons,
this kind of thing would be sempti-sferethyl pharmacology,
but usually it's medicinal plants
and not necessarily psychoactive.
And it's important to note that this is really about
indigenous societies, not what we call developed
societies, developed nations or whatever, because if it was under that definition, everything
would be ethno-pharmacology.
The two terms, ethno is people and pharmacology is pharmacology, the study of drugs, and their actions.
But so this sort of elaborate definition kind of ticks all the boxes, if you will.
It's interdisciplinary, it's biologically active substances, it's indigenous use of these
things. And indigenous people, as we know,
are very ingenious about discovering these things
in the bio and utilizing them for medicines
or poisons, food, or whatever.
Right, so you're one of a number of researchers
who's going out to, let's say, pre-scientific
locals or peoples and finding out what they know traditionally before their culture is lost so
that we can pull that knowledge into the broader scientific domain and and associate it with what
we already know and also preserve it and hopefully extend it if we're fortunate.
That's exactly right.
That's exactly right.
And much of what the McKenna Academy does
and that we're about is collecting and preserving
this knowledge, this indigenous knowledge
that is in danger of being lost,
that's rapidly being lost due to
all sorts of factors. The decimation of cultural traditions, the loss of habitat,
the loss of species, climate change, all of these things are leading to the disappearance of this knowledge. And yet there is still a lot left to be known.
So the McKinney Academy is trying to make a bridge
between traditional knowledge, preserve it,
and scientific investigation.
Science is the nexus that brings these things together.
And we have done various seminars about this,
like ESPD 50.
We currently have a big project going in Peru
for which we're seeking support,
which is to the university in Akito, Peru, UNAP. I've worked with the
the scientists there for over 50 years and there's one person there that I've
worked with since we were both graduate students. I first came to Peru in 1981 to do my graduate work.
I met this gentleman who was also a student at the time.
And we have worked together over 50 years on various projects.
He's now the curator of the Iberium at UNAP, at this university, there are burial amazones.
And we have a project going to digitize this or burial
and put it all online and make that a resource
for scientific resources or anyone
with an interest in the Amazonian flora.
This will be a tremendous repository of information about the
plants that have been collected and deposited in this herbarium over really for about 40 or 50
years. It really was established around 1970. I didn't get to Peru until 1981.
But that's a big project that's our main focus.
Now that ESPD 55 is more or less behind us,
we're working on this other more ambitious project.
Now you spent some time studying ayahuasca.
Yes.
And that's kind of an interesting story.
So maybe you could tell everybody who's watching
and listening how ayahuasca is prepared
and also how unlikely it was that that preparation method
was discovered.
And I'd like to know if you have any more insight into how in the world that ever came about.
Yes, yes, yes to both.
I so I did my PhD research at the University of British Columbia was basically about
ayahuasca, about looking at the chemistry, pharmacology, botanical sources, traditional uses of ayahuasca.
Another aspect of my thesis research was kind of a comparison
of ayahuasca with another much more obscure
Amazonian psychedelic called Ucuhei,
a psychedelic called Ucuhay, which comes from entirely different botanical sources. But like Ayahuasca, it is also an orally active form of dimethyl trip to me.
That's the key to this. DMT is a short acting psychedelic, but it's not orally acting by itself. If you
consume DMT, if you drink a tea that contains DMT or just eat DMT or whatever, it's not acting
because there are enzymes in the gut, monoeimine oxidases that will inactivate
DMT before it's ever absorbed in the active form.
What indigenous people have done when they prepare ayahuasca, they combine it with another
plant that contains monoeimine oxidase inhibitors, this class of compounds called beta carbolates, very potent,
very selective M.A.O. inhibitors.
So if you make a beverage, a drink or a decoction, it's really the technical term with a plant
that contains DMT and a plant that contains these beta carbolates, then it becomes orally active.
And instead of a 10 to 20 minute experience,
which is what you get when you smoke DMT,
or vape DMT, they do that now these days,
or inject it even, you get about 20 to 30 minutes
of an experience, but in the oral form, it stretches it out
to six or seven hours. So it's a very different experience. It's not as intense, but in some
way it's deeper. It's more profound because the thing with taking DMT by a parental route other than through the gut. It is profound, it's very intense, it's also so fast
that by the time you're, you know, by the time you're just beginning to sort of get to the place,
it's already fading, you know, so you come back with not a lot of information,
kind of a sense of astonishment,
but not a lot of hard data.
So the idea of Iowaski is you get to spend more time
in that place, in that altered state,
and there's a chance to learn more.
Now, how did this come about?
The question always comes up.
How did these indigenous people figure out this combination?
One plant containing beta carbolines
and another containing DMT,
out of the 80,000 or so species in the Amazon,
how did they stumble on this one combination? Was it trial and error? Or how?
If you talk to the people, they will say, well, the plants told us, you know, but to a
Western scientist, this doesn't make a lot of sense, you know told you what are you talking about? Actually, I think the real
story is a little more prosaic in a sense that in our ESPD 50 conference, we had an anthropologist, Dr. Manolo Torres, who presented on this.
The fact is that at a certain point, maybe a thousand years ago, possibly a little earlier than that,
there was a very active, there were different cultures that were living sort of in proximity to each
other in the region where Columbia, Venezuela, Peru now come together. These cultures were very
experimentally oriented toward plants. They had shamanic traditions and they used,
traditions. And they used, they were also very active in making chitcha. They were essentially beer producers. They distilled, or they
didn't distill them, but they have different fermented beverages prepared
from fruits and grains and things like that. And they had many different kinds of cheats,
mostly prepared from Manioc.
And they were also experimentalists.
They were like craft brewers today,
sort of, you know, craft brewers will,
they have their beer,
but then they'll just reach for anything on the shelf or an ingredient
will come up and they'll say, oh, let's make a craft brew with coffee and there with some
other some other plan. Let's make something interesting. Well, the people making the the
chichou had the same sort of curiosity. And in their medicinal pharmacopia, they had the snuffs, right?
That's the other way in the Amazon that DMT is used
in the form of snuff.
And they had these snuffs, they had these antitentanthro-snuffs,
which don't require MAO inhibitors,
because you take them, you know, as a snuff.
They also had anestereopsis, which is the vine that contains the beta carbolines.
They use that separately as a medicinal plant for various reasons.
And it has some psychoactivity.
Basically, I think they stumbled on this formulation. You know, the plants were
in the mix, as it were, and they stumbled on this formulation, but it wasn't entirely trial
and error. You know, it was more like an educated guess, not really from the standpoint of biochemistry.
They didn't think in terms of monoamionoxidase inhibition and that sort of thing, but they
were familiar with the effects of these different plants and they thought, well, what happens
if we mix them?
And they did.
They had a spectacular result.
I was talking to Brian Murerscu.
I think it's probably more than a year ago.
He wrote the immortality key.
And although a lawyer, the book is about ethno-pharmacology in many regards.
It sounds to me like the account that you're making of what happened in the Amazon jungle
sounds to me very much like what seemed to happen in ancient Greek culture with their
formulation of various psychedelic wines. That's right. So all these different people were just brewing all these different concoctions and
experimenting to see what produced the most
remarkable effect.
And in Greece, they seem to have stumbled across something
that was perhaps LSD based, or essentially LSD based,
whereas in the Amazon jungle,
they came across both DMT and the chemical
that inhibited its breakdown.
And so it's very interesting to see that that
is likely the case in both
those disparate cultures.
Right. Well, shamanism, which is what we're talking about here, shaman's are experimental
ists, you know, and many of our even most important medicines. Again, we can point to
arrow poisons. I mentioned arrow poisons before.
And arrow poisons are not regarded as medicines in the context in which they're used.
You know, they're used as poisons for hunting. On the other hand, the ingredients in
arrow poisons do have medicinal properties that have been recognized in the 20th century, and they're important
medicines for muscular surgery, and this sort of thing, they block the neuromuscular junction.
And the reason I mention the arrowplacens is that that's another example of people, what I like to characterize as mucking around with plants, you know, throw things together
and see what happens, you know, and that's true of the psychoactive plants and these different
chit-cha formulations that they have, or the arrow points, which are not just one ingredient, they're complex mixtures of many kinds of psychoact,
or, you know, more or less toxic plants.
So it was curiosity driven, you know,
that the people immersed in this Amazonian biome,
this chemical ecology, if you will, of complex secondary plant products
and driven by curiosity, you know, what happens if we take plant A and plant B and combine
them or plant A, B, C, and D and mix them all together and what happens.
So in that sense, their approach is very scientific, you know, because science really discovery
is driven by curiosity.
These folks were curious.
They didn't keep notes.
They didn't write lab reports, you know, what knowledge they had, they transmitted
through the culture, through oral traditions. And as this knowledge became, you know, more
widely disseminated, other groups began to also take the core knowledge, but then expand on it because they have species, you know, in their biomes that maybe not were originally around.
And that's the way I think folk knowledge works. It's an evolutionary process. It's a process of sharing information and accumulating this knowledge that then is, you know, transmitted
through oral traditions and through migrations and this sort of thing.
So it's not formal science, but sort of the impulse that leads to this is curiosity,
discovery, and that is at the core of science in my opinion.
So I was, I got, I want to tie a couple of things together here. I recently talked with
a doctor, Karl Friston, who works at University College in London, and he's formulated a theory
of cognitive function that's very influential, or elaborated a theory of cognitive function that's very influential or elaborated a theory of cognitive function
that's very influential and I want to run it by you because I think it's relevant to well
it's definitely relevant perhaps to your interests in the effects of psychedelics. So
Frist and another observers have posited that we look at the world through a hierarchy of concepts and that this is necessary
and that AI systems do the same thing.
And the hierarchically nested concepts
range from those that are trivial that you would just
use in a throwaway manner, let's say,
maybe your opinion about what you're going to do in the next 10 minutes might fall into that category,
to those that are the profound axioms upon which you predicate your life. So, for example,
if you're married, one of your axiomatic conceptions or presumptions or even perceptions might be the faithfulness of your partner and the willingness
of that person and you to continue to engage in your long-term relationship.
And then imagine a hierarchy of presumptions such that some presumptions are much more fundamental than others. Or in other words,
upon some presumptions, many other presumptions depend.
And then for some other presumptions there,
like I said, they're just the opinion of the moment
and easily replaceable.
Now then imagine that there's a gradient
of information processing
so that some neurological mechanisms process the relatively trivial conceptions
and others process the more profound and deeper presumptions.
Then imagine that's laid across the hemispheres,
so that the left hemisphere more or less deals with the particulars and
the right hemisphere deals with the more fundamental presumptions.
And then imagine further, and this has been reasonably well-documented now, that variants
of serotonin affect different levels of that hierarchy of conception, so that the serotonergic systems that are affected by psychedelics
affect the deep presumptions and the serotonin mechanisms that are
affected by antidepressants stabilize the entire structure.
And so what Fristens work along with car-hard Harris is indicating,
there is others working on this as well that
psychedelics
induce entropy into
the conceptual hierarchy at the most fundamental level.
And so, and maybe that's associated. The hemispheric specialization element is something that I
added to that
The hemispheric specialization element is something that I added to that set of presuppositions partly because of investigations I've done into hemispheric specialization, but also
because of the work of Ian McGillcrest, who's been positing such things.
So it looks like the psychedelics effect systems that are naturally affected by high levels
of stress because when you're extremely stressed, maybe that's a affected by high levels of stress, because when you're
extremely stressed, maybe that's a time to revisit some of your fundamental presumptions,
because something has gone wrong in your life so that you're fundamentally stressed.
And so, in some sense, what the psychedelics seem to do is mimic the process of revolutionary
cognitive adaptation.
Okay, so that's only half the question. is mimic the process of revolutionary cognitive adaptation.
Okay, so that's only half the question.
But then I have another question though,
and that all strikes me as highly plausible,
except for one thing,
and this is a stumbling block for me,
and maybe you can shed some light on it.
I know this is a complicated question,
but I read Rick Strasman's book, The Spirit Molecule,
after meeting you, I believe, and I know
Dr. Strassman, who's a pretty, let's say, mainstream psychiatrist, was quite shocked to put
it mildly by what his research subjects were reporting as a consequence of being administered
DMT. They would report being shot out of their body and then going to other places and encountering
what were essentially alien beings of one form or another.
And when Strasmon would suggest to such people that this was like a dream or maybe they
were encountering something akin to a Jungian archetype, they would say,
no, you don't understand, this was more real than being in reality itself.
And so, this is the thing that doesn't fit for me, is that, and I know that in the
shamanic rituals that are associated with ayahuasca, people often report encounters with entities.
And I don't understand how that, if that's true, and I believe it to be true phenomenologically.
I don't understand how that fits in with the idea that what the psychedelics are doing
are loosening the constraints on our most fundamental presuppositions.
And so, sorry for the tremendously long build up to that question, but it's a complicated
question. And I'm wondering what you think about, well, first of all, the theory that psychedelics
do loosen up our conceptions at the most fundamental level. But then how you square that with the reports
that people make continually of meeting entities of one form or another, well, they're under the influence of these chemicals.
Right, well, how long have we got here?
I mean, it's gonna take a while to unpack this.
Good, good, but I'm looking forward to it, man.
As to the first part of this,
the car heart Harris notion that psychedelics, I think one way
they put it is that they disable temporarily this so-called default mode network, which
is kind of the framework that we construct, I like to call it the reality hallucination.
It's the model that the brain creates, the model reality that we inhabit.
We don't inhabit reality itself because it would be too overwhelming. What we experience is a schematic or a model
of reality that is much less information dense than reality itself. And the brain does
this in order so that we can cope with it, you know. A lot of what the brain does is you
well know you're a neuroscientist, at least to some degree. a lot of what the brain does is you well know, you're a neuroscientist,
at least to some degree, you know that what the brain does is filter information out.
There are gating mechanisms, a lot of information from the external world through our sensory
neural interface, never makes it into the brain because it's not, it's, I mean, it's not that it's
not important. It's just extraneous to our construction of this model of
reality that we have to inhabit just in order to navigate, you know, in order to
function. And what psychedelics do is they temporarily disable those gating mechanisms.
They just throw the gates wide open. And you get flooded with all this information that normally
is not accessible. And that can be a very useful thing from a therapeutic angle because we can get trapped in our default mode network,
in our reality hallucination, if you will, our reality model.
It can be dysfunctional, it can be not helpful.
And then you get things like addiction and PTSD and so on. And I think something, I think the core of the therapeutic
use of the therapeutic promise, if you will,
of psychedelics is they let you step out
of this reference frame temporarily.
Look at it as though you're separated.
And it helps give you insights as to
your existential situation.
So it isn't able to look at trauma or addiction
or depression or things like that
from a different angle, a different perspective
that normally we can't,
because we're trapped inside this default mode network framework. And I think that's helpful. And I think that
that lets you reengineer it in a certain way. And this is actually reflected on the neurological
level because we know that civil society and things like this can actually lead to changes
in neural architecture and connectivity
and all of these things, neuroplasticity
is the sort of overarching term for this.
And it's really, so you disrupt,
you blow up the default mode network.
But the brain is resilient, the brain is always going to tend toward equilibrium, right?
So it's going to fall back together.
But it's going to fall back together in a more functional way.
I think it's very similar.
In fact, maybe I think it's quite similar to
what happens when you reboot your computer. You get this big reset essentially. And it
comes back together, but it works more efficiently because it's, you purge all the clutch out
of it that builds up in the system.
And that's it.
It's very much like sort of purging your computer.
When you reset it, you get rid of all that stuff.
And it works more efficiently.
So that's important, I think, for the therapeutic.
That's really the therapeutic promise.
Almost everything that psychedelics, that people are excited
about psychedelics from a therapeutic standpoint, I think has to do with this ability to, you
know, first of all, disable and then reconstruct the default mode network in a way that's more functional and, you know, more, more, well,
simply in a way that's more functional, less, less dysfunctional. So I think that's what's going on.
Now, when you blow it up, especially with something like DMT, which is where you get more than other
places.
But Ioski, these other things as well, you sometimes have a feeling or you get a definite
sense that you're in a place where, as people say, it seems more real than real.
And there are entities there, or what's perceived to be entities.
And you're in communication with them.
And they are very interested in communicating and transmitting information.
I mean, so a number of questions come up about this, right?
People have these experiences, not always,
not always on all psychedelics, not every time,
but under some circumstances,
people have these experiences.
I just came from this conference in the UK
a couple of weeks ago.
So I'm well primed for this because this was the topic
of the conference.
It was called the sentient other
and everyone was presenting their ideas about the entities.
presenting their ideas about the entities. I am, useful reminder of how little we know about the universe,
about reality, about the way things are. In that sense, it can be very useful because science,
especially in scientists particularly, tend to be arrogant.
There's a tendency for science to say,
we pretty much have this thing figured out.
And psychedelics are a reminder that no,
actually we have only a very tiny slice of it figured out.
And even that is subject to question
because that's the nature of science, right?
You never prove a theory.
All you can do is not disprove it.
You know, so we understand in great detail
a very small piece of reality.
But there's an infinitude of reality beyond that
that we know basically nothing.
So we need science, science and scientists should be humble.
They should always keep that in mind, how little we know.
That said though, so with that preamble, I do have to say, you know, reductionism or skepticism or what they come sometimes called
Occam's razor approach, the principle of parsimony is a useful tool in science.
Because it is a statement that what explains the data, the simplest model that explains the data, let's start there.
And then it's shortcomings, it's limitations, it's deficiencies.
We'll come to light as we begin to investigate phenomenon, eventually we're going to, but science starts with hypotheses
about the way things are, what my granddad used to call how the borate the cabbage, you
know, it begins with theories about the way certain aspect of reality is you create
a hypothesis, you test it against the observed data. And if something comes up
that the data, you know, can, that your model can't explain, then you say, okay, the model is
deficient. We either have to modify the model. Maybe we have to blow up the model. Maybe it's
completely invalid.
Usually that's not the way it works.
I mean, you tweak it, you change, you know,
a thing here, a thing there,
and you make it fit better with what, you know,
what we presume that we know, right?
When it comes to entities,
here's the thing. I know that people say, oh no, this is real. This is more real than reality
itself. But you know, people are not epistemologists. People are not qualified to say, what is more
real than reality itself. You know, I mean, people may think it's more real, it may seem more real than
reality itself. We've all had vivid dreams, right? And we wake up and we think, oh my god,
you know, that was so real. But you know, it was a dream, right? Because you woke up
and it's not there. And so I think that the judgments made by people
who encounter these entities,
the fact that they have this impression
that these things are real and more real than real itself
does not necessarily make it so.
Okay, so let me ask you this. So obviously when we dream, as you pointed out, we can encounter entities of our imagination.
Those are other dream characters.
I had a client once who was a lucid dreamer and a very good one. And she could actually ask her dream characters what they represented symbolically and they
would tell her.
And so, okay, so let me modify the question that I posed to you before and tell me what
you think of this.
So, we know that the psychedelics produce an increment in trait openness.
And we know with the psilocybin in particular, that if people have a mystical experience
with psilocybin, once or a couple of times, that their level of trait openness, which is
the creativity dimension, increases by one standard deviation, and that appears more or less
permanent.
So we could say that one of the things the psychedelics do
by loosening the strictures on the more fundamental realms
of conception is place people into a state that's analogous
to the state of creativity.
And so if you're creative, you can shift conceptions.
And the downside of that is you shift them when it's not necessary
and the upside is now and then you shift them in a direction that's extremely productive.
And so that shifting becomes more possible under the influence of psychedelics.
And then we could say that, well, it's possible that one of the
that one of the sources of creativity might be the capacity of the human imagination to generate fictional personalities. We do that in dreams. Obviously, your brain is, we would say, your brain is producing these fictional characters that have many of the attributes of real characters. When you dream, you can see them, you can hear them,
you can interact with them.
You don't have immediate access to their contents,
contents of consciousness.
They seem like autonomous beings.
And so we could say, maybe what happens
when you're experimenting with psychedelics
is that you enter a dream's scape
that's populated by creatures of the imagination
that have a certain degree of autonomy
and the influx of information that's also characteristic
of the psychedelic experience produces that sense
of hyper reality that's then attributed to the characters themselves.
Does that seem plausible? I know it's just a hypothesis, obviously, but it is.
Right. The art too. It does. I mean, obviously all we're doing is trying to construct hypotheses,
you know, that fit the data, that fit what we know so far, always with the caveat that we
don't know much and the picture is incomplete and so
on.
But here's the thing.
I think, I mean, the question perpetually that comes up with these entities is you encounter
these entities in the psychedelic state.
And then the question is, are they real?
But I think you have to step back from that.
And first of all, you have to say,
well, what do you mean by real?
Well, yeah, that's a problem, man.
Yeah.
That's a big problem.
I mean, my sort of default position is
anything that you experience is real.
It's real because it can be experienced,
but is it
originate within?
Is it come from the collective unconscious?
Does it come from out there in some other dimension
and do these terms even make sense?
I mean, you just get into an epistemological mess
because how can you even posit there is an outside? I mean one one thing
that psychedelics do is they teach you it's all one you know there's no separation between the
self and and the cosmos and large and all that so so it's like it's a non-, it's a zero sum game to, you know, to maybe it's, maybe it's, maybe it's
more useful to say, rather than to say, are they real?
You know, because they're real enough that they're experienced.
So in that sense, they're real, whether they're inside or outside, originate from the self
or some other dimension.
Maybe the question we should ask is,
is the information that they transmit useful?
Can we learn from it?
Can it teach us something that we could not otherwise know?
And that seems to me potentially a more useful question.
My brother was all about this. He would take high doses of mushrooms,
by himself, and in total darkness. That was his formula. He wrote doses and told darkness,
and he would have these dialogues, these conversations with these entities.
And it was all about how do I know you're real?
How, or more like, can you tell me something
that I cannot possibly know?
And if you do that, I'll know you're real.
And they would say, well, we don't care if you think
you're real or not, you know?
But, and then again, how do you define something
that you can't possibly know?
And if they say, I mean, you can say, give me the square root
of a large number.
And if it comes back and it turns out it's correct,
as trivial as that is, that would demonstrate
that it was real information.
They're giving to you, but it still doesn't really.
No.
You know, and there are mathematical geniuses
who can do that.
Yeah.
Yeah.
Well, okay, so let me push on that a little bit.
Everything that you said so far
seems to me to be rock solid.
So with regards to these entities again,
so I was reminded of two things.
I mean, Carl Jung spent years talking
to entities of his imagination, documenting
that books like the Red Book.
He made that a visionary practice
and had
illuminating conversations with
specters of his own imagination, but of course he also believed that there was a collective element to those.
And so you might say that
well to the degree, for example, that we're each inhabited by dark
impulses, we might say, well we're each inhabited by dark impulses. We might say, well, we're each prey to the same demonic forces.
That's one way of thinking about it.
And they're the same and they're transpersonal.
And they exist to some degree cross-culturally.
And they span time.
And so these creatures of imagination can have histories
and can inhabit us in some real sense.
And they can do that
collectively.
And then, so that complicates things tremendously.
But then I would also ask, in your investigations, your long-term investigations of multiple
ayahuasca experiences across different people, are there any commonalities of entities
that strike you as particularly
significant?
I know people talk about clown figures, for example, mechanical clowns in the DMT state.
Like the elf machines in this sort of thing.
Elves.
Yeah, exactly.
The elf machines.
And of course, that's complicated, too, because once one person starts talking about it,
that might increase the probability that other people would experience it.
But have you seen commonalities of entity experience that would suggest something, the existence
of something that is at least transpersonal, even though it might also still be subjective,
whatever that means in such a context. Yes, yes, I have and I think this exists in these in these
shamanic traditions and the ayahuasca is a particularly good
good example of that, you know.
And again, I have not seen anything that convinces me.
I mean, I'm basically a Jungian, you know,
so I believe in the collective unconscious
as this, it's a good model,
this trans-personal realm of shared archetypes
and all that, and then there's the individual unconscious. I haven't seen anything in the reports of the psychonauts that would not fit into that model,
that says, oh, well, this doesn't really fit.
This is outside that model, and so that model is not valid.
I haven't seen that.
I think that it is, I think basically these entities, they are experienced as real,
but they come from the collective unconscious. And if you look at the Iowaska traditions,
and there is an interesting book here that's very illustrating of this, which many people know about.
It's the book that, you know,
familiar with the artist Pablo Amaringo,
the visionary Peruvian artist,
he and Luis Eduardo Luna wrote a book.
He painted his visions, right?
He remembered all his visions in perfect detail.
Painting these visions, right? He remembered all his visions in perfect detail, painting these visions,
and Eduardo, and he collaborated on a book called Ayahuasca Visions, the Religious
Iconography of a Peruvian Charmin. It's still in print. The book is remarkable because it's its typical coffee table style format with full color illustrations of the visions on one page and then word those descriptions in English on the facing page dissecting all the elements of the entities and everything else that you see in these visions.
As narrated by Pablo, you know, Eduardo Luna was basically just the transcriber,
but Pablo described in great detail dissecting each one of these paintings. And they're about, I guess, 20 or so
of these paintings in this book.
And it's basically a course in vegetalismo.
It's talking about vegetalismo, this practice,
which is really a mahogam of many indigenous traditions and kind of mush together into a
mestizo tradition, but he describes these entities, you know, they all have names,
they have a particular appearance, and you know, the plants, the animals, even, you
know, there were UFOs, there are all kinds of things
in these visions.
Pablo describes every one of them.
And any Iowaskero in training work, you know, in my parentheses under Pablo or any of
these traditional I scurals,
they're gonna see these things.
I mean, this is a cultural context,
they're gonna see these things.
And what they see is gonna be similar.
So it's sort of like Terrence's self-transforming
elf machines.
I mean, Terence says that, you know, he has
a huge voice in the meme sphere pretty soon, everybody's seen self-transforming elf machines,
you know, people, that's what people see.
Well, you can imagine, you know, the brain is obviously an organ that can produce personalities, because it produces our
personalities.
And it seems to me that it's highly probable that the way that we organize information
is in the form of personality.
So I certainly got a fair bit of this from thinking about Jung's work.
I mean, if you're inhabited by a rage state, which I think is a good way of thinking about it,
you might think, well, what form does the anger take?
And the answer is, well, it has a personality.
You might act like enraged people that you've seen in movies.
You might act like enraged people that you've seen in movies. You might act like enraged people that you've seen in your life.
The rage has a goal, which is the crushing of the opponent, let's say, and it has perceptions
and it has action patterns.
It's a personality, and you could conceptualize the rage spirit as aries, the god of war,
and that would be a perfectly reasonable way of looking at it.
And it could be that all of our micro perceptions
and all of our macro perceptions for that matter
have the intrinsic form of personality
and that that's partly what we encounter when we dream.
And so I was thinking too, you know, that as the gods,
if the gods are aggregates of micro personalities,
that might be one way of thinking about it.
They're micropersonalities that are aggregated
within societies across time,
and then can be apprehended collectively to some degree.
As you move towards a monotheistic vision of the world,
what you're moving toward is the ultimate aggregation
of all these socially modified micropersonalities
into one conceptual scheme.
And that would parallel that hierarchy
that of cognition and conception
that while we already discussed
that people like Fristin are working on.
And so it isn't that surprising, I suppose,
if you think about it that way,
if the brain is a personality producing machine, so to speak, that there are certain states that you can encounter under the influence
of chemical alteration, where you encounter those personalities, even those that have some
degree of autonomy.
I mean, rage has some degree of autonomy, and so does lust, and so does thirst, and so does
hunger. They're not exactly you,
their forces or personalities,
which is a more accurate way of thinking
about that you can fall prey to.
And so why can't that occur in a more complex manner?
Well, I think it can.
I mean, this totally fits within the Jungian model,
that within the Jungian model,
that within the collective unconscious,
there are these, I forget the exact term that he used,
but these complexes, almost like autonomous personalities,
and multiple personality disorder is a recognized thing. And I guess in some ways,
all of us have it in a certain sense, in that we have, we do have these multiple personalities,
but they like rage, lust, and so on. But they don't take over the controls,
most of the time they're suppressed to a certain degree,
but they're always there and they're influencing
whoever it is in the cabin, at the bridge
that's running the thing, and in pathology,
they can take over.
And then you've got a problem.
Well, they do with Tourette syndrome.
They do with Tourette's. They do with Tourette.
They do with obsessive-compulsive disorder.
They do with obsessive-compulsive disorder.
And, you know, and you can think about the relationship
between these motivational states, like rage or anxiety.
Let's say that are transpersonal in that everyone experiences them.
We know that with the psychedelic experience,
that set is very important,
and that if someone is in a negative emotional state
or situation that elicits fear and, let's say, rage,
and then they embark upon a psychedelic experience
that that particular state can be magnified beyond belief.
And so that's a good way to have a hellish experience.
And so, you know, we do have to remember,
and I know of course you do,
that the psychedelic experiences that we're talking about
are ritualized so that an absolutely dreadful outcome
is less probable.
But you might say if it was just done randomly,
it could easily be the magnification
of a state of terror or a state of rage as
the magnification as a state of enlightenment or bliss.
Right.
So this is the importance of the ritual, of the ritual context.
This is exactly that what these traditions have grown around is the idea that there needs to be an appropriate set and setting. There needs
to be an appropriate set, the most important variable, certainly. And I sometimes say in
my talks, I say, Iawaska is a liquid. Iawaska will fill any vessel you create for it. You know, and hopefully the vessel is appropriate to foster a positive experience and insights and all that.
But we know that it's not always that way.
We know that, again, like with any spiritual tradition where you're finding, where you're dealing with powerful spiritual forces,
they're always bad apples, you know, they're bad shaman, they're bad shaman who's
don't have your best interests at heart, you know, and there's a term for it in Iowasca.
It's called Ruharia, I mean, basically witches or sorcerers.
They have this understanding.
These people are power freaks.
They want control over other people.
And they'll often use Iowasca that way.
They'll often spike their Iowaska with
Dittura with Brookmanzi, which is a drug that basically renders people both delirious
and confused, but also very suggestible. And it's used as a date-rate drug and things like that.
Some, you know, bad shaman's will put that stuff into ayahuasca.
So you want to be careful.
There is no good housekeeping seal for ayahuasca, you want to be careful who you get mixed up with.
Right.
Well, the same thing applies when you're looking for a psychotherapist.
I mean, in terms of the importance of set in relationship to positive transformation,
I mean, Carl Rogers tried to lay out some of the preconditions for successful psychotherapy.
And so I'll just run through those because they're very much akin to the manner in which
the stage needs to be set for a positive psychedelic experience.
So Rogers, essentially, I'm paraphrasing, but it's okay.
So first of all, the person who's coming to psychotherapy has to want to change.
It has to be voluntary.
And that's actually something that's
being hammered home by now generations of psychotherapeutic
practitioners, regardless of their theoretical school,
that voluntary exposure to information
that might have a transformative quality
so that can be threatening.
Voluntary exposure is redemptive.
It has to be voluntary.
So you have to want to change. And then if you come to psychotherapy for it to work, it has to be
embarked on in a spirit of mutual trust. And so there's some courage there on both the part of
the practitioner and the client. And then you also have to swear or vow in some sense to engage in truthful exploration
and dialogue.
And so you have to admit you have a problem, so there's a certain humility there.
You have to be willing to learn and change.
You have to engage in truthful exploration and dialogue, and you have to be aiming for
improvement.
And if all of those things are there, then, well, in principle, the psychotherapeutic process
can begin.
And you might say, well, if all those things are there, then learning itself can begin.
And it might be that the set that is being established at the beginning of a psychedelic
experience is just precisely akin to establishing the preconditions for learning
and personality expansion itself.
Because, you know, in this conversation, you and I, well, look, we're sitting here, we're
kind of relaxed, we trust each other for a variety of different reasons we've met before,
but I know of your reputation scientifically, and I trust your work and and and so we can embark on a creative
a creative dialogue that's hypothetically mutually redemptive because we're
both going to learn something and we can bring everyone else along for the
ride and I don't really see that as any different in some fundamental sense
than establishing the proper set for a psychedelic experience or the proper
preconditions for any relationship,
including a therapeutic relationship. Right. I think you're exactly right. I think those preconditions
are an almost exact match for the ideal set and setting. You know, I mean, there's a great deal of
set and setting. You know, I mean, there's a great deal of emphasis on the set, the setting,
the set. And I don't limit the set to just, you know, in my mind, it's everything you bring to the table. It's not just your mood at the moment or, you know, it's everything you bring to the table. It's you, you're the cent, you're always the cent,
but you're bringing it to this very special situation.
And then the other variables that are sort of in the background,
not often mentioned, but very important are the dose and the medicine,
because that's part of this four-part dynamic of variables that's
going to interact. And the most important thing about a therapeutic psychedelic session,
really, like you say, it applies to any therapeutic session. It's number one, you know, a safe setting, a safe setting where you feel
you trust the other person, you feel that the situation is safe, not threatening, and you're
willing to learn. You're willing to surrender. You do everything you can to to make sure everything is kosher. And
then at the critical moment, you just have to let go because that's an important thing.
You have to say, okay, let go. You know, I mean, it's kind of like jumping off a cliff
or out of a plane. You trust that the parachute is going to open at some point, you know,
and you just have to accept that.
Yeah, well, we do that while we're talking you and I. I mean, because at the beginning
of this podcast, neither of us knew what direction the conversation was going to take, but what
we're doing in some sense is loosening up our cognitive structures.
You and I both have some perspectives on what the psychedelic experience might consist of
and what psychological transformation means, but we're willing to play with that to some
degree.
And so we're willing to open ourselves up to the transformative process that obtains
during the course of what we try to make into a genuine dialogue.
And so, and again, I do see that is exactly the essentially exactly the same thing.
And I think you can think about it in terms of classical virtue in some sense.
So what you want to do is bring an attitude of humility and courageous trust to the situation.
And the humility would be, well, you know, good as I am,
I probably still have a few things to learn.
And the courageous trust is, well, if we undertake the process correctly,
then the information that will be generated will actually be of benefit to everyone involved.
But that's a statement of faith in some sense, right?
Because you don't know that to begin with. But then's a statement of faith in some sense, right? Because you
don't know that to begin with. But then it's faith in the dialogue, essentially. And I don't see that,
as being particularly different in the psychedelic situation. You know, I don't either. It's exaggerated
and intensified. Exactly. Exactly. What have you made of the research that's being conducted
in the labs at my Roland Griffiths and his crew?
Well, obviously it's groundbreaking.
And Roland and his colleagues are,
they have set the bar very high,
and they're the pioneers for sure.
And everyone else is kind of following along from that.
I think that they have, particularly in their work with end of life,life anxiety and this sort of thing. I mean, I think that's
setting new paradigms for medicine. And it's addressing a really important deficit
in medicine, right? Because medicine, the way it's practiced, myomedicine, I sort of make a distinction there
from say alternative complimentary medicine,
but myomedicine is about preventing people from dying, right?
And they will go to great lengths to keep people alive,
maybe to like in certain, like cancer therapy and this sort of thing,
maybe going too far to keep people alive. It's like survival at all costs.
Medicine needs to face the fact that everybody dies. You know, as sooner or later,
the therapy is going to fail, no matter what it is. But to view it as a failure is an incorrect perception.
At a certain point, you have to reach a point where you say,
this patient, this person is not going to live.
Rather than focus on keeping them alive at all costs,
let's think about giving them a peaceful death, you know, facilitating
a beautiful death.
That concept that death can be beautiful is something that is missing from medicine as
it's a practice.
And I think that psychedelics offer an opportunity to reintroduce that concept, you know.
Right.
So just to review for people who are listening, so Roland Griffiths, who conducts psilocybin
research at Johns Hopkins and is a very solid scientist, to say the least, has produced
studies showing that with patients who have a terminal prognosis of cancer that a mystical experience induced by psilocybin
can produce a profound reduction in mortality related anxiety.
And that's a very sterile way of describing
what's actually a remarkable event
because it sounds in some sense like it's reduced to
simple awkums razor chemistry. You give people a dose of
psilocybin and they're less anxious. It's like, that isn't what's happening, what's happening.
And we don't know the details of what's happening. What's happening is that, imagine that one of
the canonical fears that people bring to life, existentially, is fear of suffering and mortality.
I mean, that in public humiliation and excommunication are probably the two big classes of fear.
So we'll say fear of mortal suffering.
And then a mystical experience undertaken under the appropriate circumstances can reduce
the fear of mortal suffering itself under the most dire circumstances, and the dire circumstances would be
when directly confronted with the inevitability
of mortality and suffering.
And so, but I haven't been able to gather
much information on exactly how the transformation
that's induced by the psychedelic substance
actually makes itself manifest, because
that has to be a very fundamental cognitive and perceptual retooling to be much more sanguine
in the face of death itself.
Very big things are shifting underneath the surface.
And so, do you have any sense with your vast experience in such domains?
Do you have any experience or any sense of what it is that shifts?
Yeah, I do.
I think again, it goes back to this, what we were talking about before,
about stepping outside your cognitive reference frame,
stepping outside your default mode framework, whatever
that might be, giving you a chance to look at death as you might look at any problem that
you have, anxiety or trauma or whatever, look at it from a different perspective.
What has impressed me about the reports of people
who have had this end of life therapy with psilocybin?
What seems to be the therapeutic,
what is most beneficial for them is they come away from the experience
and they're not preoccupied with death anymore. They're not looking ahead
to this moment of dying. They know it's out there, but their attitude is, well, wait a minute.
I'm alive now. I'm alive at this moment. Let's focus on that. Death is there.
It will come.
But I think that's tremendously helpful for them
and anxiety relieving to say, let's just focus day-to-day
on the moment, being alive in the moment.
And that relieves their anxiety greatly.
And it's interesting that you know, that, you know, we don't evaluate, like many cancer drugs,
chemotherapy, and that sort of thing.
They're evaluated, their effectiveness is based on how much, how long did they prolong life?
You know, did they live longer than would be expected if they didn't take this chemotherapy.
Often many of these things do extend life, but by the time you finally die, you're just
your wreck.
It destroys the body.
It's interesting that nobody is claiming that psilocybin cures cancer, but it certainly
can extend life, you know, beyond expectation. I mean,
there's a woman up here that there's a movie out called Dost 2, and she, I've been in this movie
part of it called Dost 2, and she started out with terminal diagnosis of, I think it was colon cancer, liver cancer,
or something. She was told she wouldn't have, she would live about six months. That was five years ago.
You know, she's had two psilocybin sessions. You would never think of this person as being sick.
They don't appear to be sick.
Her attitude is good.
And you know, she knows she's dying, but she doesn't live every moment
anticipating that.
She's more about.
She's living in the moment.
And it really, it's beautiful to see,
you know, because her family life, her relationship with her husband, her friends and all that,
that's what she's enjoying and she's having a good time. Everybody knows she's going to die
sooner or later. They've stopped
predicting. But that then again, as you said, that's also that's true of all of us
to some of you. Of course. Yeah. And then can come at any moment and to be
preoccupied with that, obviously, can produce very counterproductive
consequences. Well, so I just did a lecture series on the Sermon on the
Mount for this Peterson Academy that we're putting together online educational initiative and I want to just run that by you for a second in relationship to what we just described so as far as I can tell the ethlies of the field do not toil and do not spin.
It's not a hippie, though, it's at all.
It's certainly not tune in, turn on and drop out.
It's two parts.
The first part is, it's to love God with all your heart and soul.
That means to me, technically speaking, psychologically speaking, let's say, to do something like orient yourself as much as you possibly can to the highest
good that you're capable of conceptualizing. And so, for example, when you're in sconst
in a family and facing a mortal challenge, one of the higher goods that you might attend to is
to make the most out of every moment that you have
with the people that you love.
And so, and then once you're oriented in that direction,
then to pay as much attention to the moment as possible,
to let the day be sufficient,
let the troubles of the day be sufficient to the moment as possible, right? To let the day be sufficient, let the troubles of the day be sufficient to the day.
To stay safe.
To say that, sufficient unto the day
are the troubles therein.
It's an injunction to focus on the moment.
And then you might say, well,
there is a tremendous amount of information in the moment,
a tremendous amount of redemptive information, and the more you pay attention in the moment, a tremendous amount of redemptive information,
and the more you pay attention to the moment,
the more you open yourself up to,
what's in some sense,
the infinite complexity of the moment.
And so you might say,
if you weren't yourself properly,
and that would be a matter of getting the set right at all times,
not just when you're preparing for a psychedelic experience.
If you get the
set right and you open yourself up to the moment, then you can find all the meaning that
you need to immerse yourself in life in that moment. And that's dependent on the intensity
of your attention. Yeah, well, that's okay. So that's very, that's very useful, that
conceptualization. So your sense is that it turns people's, the insights, the mystical insights,
turn people away from the precipice of death to the infinite possibility of the moment.
Exactly.
That fear of death might be one of those screens, in some sense, that are blocking or
inhibiting the flow of redemptive information.
And so the psychedelic experience obliterates that
and says, remember what's right in front of you.
Yeah, and the fear of death is, you know,
this is what the psychedelic experience helps diffuse,
you know, by refocusing on the moment.
I am hopeful, I don't know if it will ever happen. But
I think the next step in psilocybin or psychedelic therapy for the end of life and interesting threshold threshold could be crossed, if you will, if people would, if you could arrange this therapy
so that the family members could also participate with the dying person.
Can you imagine the dynamic that that would let that that would engender, you know, people to share this
experience of, you know, the loved ones, impending the mortality, impending mortality for sure,
but just the richness of the relationships, the ability that psychedelics give you some time to honestly relate to your loved ones, you know, in a way that is unfiltered and you know how hard it is sometimes for us to really express to someone our love, you know, even though we love them, but sometimes the words I love you is a hard thing to say.
You know, and I think it would be very helpful for the family to be able to not only be present,
but also be in the altered state with the people, you know, and because it would be as healing for them
as it is for the person who is dying.
Yeah, well, I've noticed that I've noticed that families who cope well with the impending death
of someone that's central to the family often do that in no small part by paying increased attention to the remaining relationships.
And so that as they lose one, they deepen the others
and sometimes in some sense as a consequence of that loss.
Right? And so that might be an analog
to what you're describing.
I guess the trick with a family would be
to try to get the set of the entire family
matched to the circumstance because it is also the case that the stress that
impending mortality can can place a
family within can also bring out the pathologies and divide people further and so
So bring out the pathologies and divide people further. And so, but obviously that's a suboptimal situation.
It's worth exploring.
It's tricky territory.
And again, I think if we look to the indigenous model, you know, as probably something we
should look at as a way to approach this, because they often do exactly this kind of thing. But they're very much more about
the collective and all that. So it's just an idea. I mean, it'd be interesting if it could happen.
Yeah, well, I don't think any experiments have been done yet on like family experience of collective family experience of psychedelic
transformation, for example.
We haven't got that far in the scientific analysis of such things.
Hard to get FDA approval for that, but it's worth attempting to do that because I think that would again be a significant step toward
creating this new paradigm around death.
That medicine, that's a big deficit of medicine.
This idea that death can be, death is inevitable, but death doesn't have to be terrible.
So that's the frontier. Hopefully that can be explored.
So let me ask you about your plans for the future. So what looms on the horizon for you and your work at the moment?
Well, right at the moment, my work is,
I'm not really doing research in psychedelics anymore and never really worked in the therapeutic area.
I was always kind of a nuts and bolts guy
looking at the plants, the molecules, the pharmacology and so on.
Right now what's occupying my time is this project in Akitos with the Eurbarium. That's going to be
a two to five year project. I need to raise somewhere between $5 and $10 million.
I should mention the McKinney Academy is a 501C3.
We're happy to accept your money.
And that's what we're gonna put our resources
as well as doing additional conferences
in a, you know, and retreats,
to some degree, but our main focus
is gonna be this big project.
And then we'll probably do another ESPD conference
in a few years, but it takes a lot of effort
to pull that off.
So it would be fun to come to that.
I wish you couldn't come next time for sure.
Yeah.
You've been immersed in the psychedelic world
for a very long time.
What has been the consequences for you personally
in terms of the way that you look at the world?
And maybe we could say the pot,
what's positive about what you've experienced
and are there things you regret
or cautions that you would put forward as well?
Well, no, there's, I mean, you make choices in life. You know, always you make choices and every choice you make closes off other choices.
Sometimes I look at my career and I wonder, you know, I could have been a better academic. I
could have had a more stellar career and academia and so on. But, you know, what drove me, what drove
me was curiosity. We get back to that original
idea. What I was interested in psychedelics emerged early in my life as the most interesting,
not just the most interesting drug, but the most interesting thing on my radar. And I
sort of grabbed on to that and I really have followed that ever since.
What was true 50 or 60 years ago is still true.
Psychedelics are the most interesting thing on my radar.
But my era, my phase of doing active research on psychedelics and so on is probably over.
And so now I just talk about it.
And as a researcher, I am looking at what I can do to preserve
Indigenous knowledge, preserve biodiversity, slow down
the devastation of the Amazon.
A very small part, really, of the total thing,
but it's what I'm trying to do.
I don't have any real regrets.
I have, in fact, psychedelics have been an unallied blessing for me
in the sense that I've learned a lot.
I feel like from psychedelics and the people
I've encountered and the experiences I've had along the way have all been rich and really
I cherish them.
I mean, I'm getting to the point now. I'll be 72 in December.
Hopefully I have some time left.
I mean, I'm not ready to check out.
But you never know, as you get older,
you get different health problems crop up and so on.
So you never really know how long.
But whatever happens, I'm happy with the journey so far.
It's been marvelous and I've been able to meet so many interesting people and go interesting
places and meet people like you, for example, and just have these great conversations.
So no regrets.
Well, that's a lovely place to stop
and we've come to the end of our discussion as well.
And so I would like to thank you, Dr. McKenna,
for agreeing to talk to me today
and for sharing your insights into this remarkable domain of
ethno botanical research and research on the psychopharmacological frontier.
And I wish you luck with your documentation project and with your upcoming conventions.
I think that would be something quite remarkable to attend.
And so maybe you can keep me in the loop with regards to the timing of the next conference.
For all of those who are watching and listening, I'm going to spend an extra half an hour,
as I always do with my guests, talking to Dr. Dennis McKenna, we'll talk about the particulars
of his career, which I think will make for a very interesting discussion.
Hello, everyone.
I would encourage you to continue listening to my conversation with my guest on dailywireplus.com.